This week’s updates include OPPS 2017 proposed rule; clarifications to stem cell transplantation for multiple myeloma, myelofibrosis, sickle cell disease, and myelodysplastic syndromes change request; and more!
My understanding is that under the 2-midnight rule CAHs cannot go past two midnights of observation care if the patient has Medicare as a payer. Is that correct?
CMS released the 2017 Medicare Physician Fee Schedule proposed rule yesterday, with policies that look to expand an Innovation Center program, revise payment for care management services, and collect data regarding global period payments.
CMS proposes aligning its conditional packaging modifiers and deleting a much-maligned modifier for separately payable laboratory tests in the 2017 OPPS proposed rule, released July 6.
